AMBER SHOULDERS: Open Payments
NPI 1386256592 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,906 in 117 payments from 39 companies in 2025. Trend: 2023 $1,185 · 2024 $2,187 · 2025 $2,906
Food & beverage: $2,781Education: $126
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $326 |
| AstraZeneca Pharmaceuticals LP | 10 | $261 |
| Regeneron Healthcare Solutions, Inc. | 15 | $243 |
| Merck Sharp & Dohme LLC | 8 | $231 |
| Novartis Pharmaceuticals Corporation | 8 | $212 |
| ABBVIE INC. | 7 | $143 |
| Gilead Sciences, Inc. | 2 | $117 |
| PFIZER INC. | 5 | $109 |
| Daiichi Sankyo Inc. | 4 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $96 |
Products named: LIBTAYO, KEYTRUDA, KISQALI, REBLOZYL, Trodelvy, CARVYKTI, RYBREVANT, VENCLEXTA.
Industry payments across TN — which companies pay providers there.
